News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|December 1, 2002

Supplements and Featured Publications

Health-Related Consequences of and Treatment Strategies for Overactive Bladder
Volume 8
Issue 19 Suppl

Health-Related Consequences of Overactive Bladder

Author(s)Todd H. Wagner, PhD, Teh-wei Hu, PhD, Judith Bentkover, PhD

Download PDF: Health-Related Consequences of Overactive Bladder

Articles in this issue

almost 24 years ago

Article

Participating Faculty

almost 24 years ago

Article

Health-Related Consequences of and Treatment Strategies for Overactive Bladder

almost 24 years ago

Article

Health-Related Quality of Life Patients Receiving Extended-Release Tolterodine for Overactive Bladder

almost 24 years ago

Article

Long-term Health-Related Quality of Life of Patients Receiving Extended-Release Tolterodine for Overactive Bladder

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Pregnant woman | Image credit: pressmaster - stock.adobe.com

Early Signs of Success for Missouri’s New Notification of Pregnancy

ByAbigail R. Barker, PhD,Nadim Kanafani, MD,Kelley M. Peters, MS, RN, BSN,Rashmi Srivastava, MD, BS

September 15th 2026

AJMC commentary

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

AJMC original research clinical

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

AJMC original research policy

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

AJMC original research managerial

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Trending on AJMC

FDA Clears First Alzheimer Blood Test for Adults as Young as 40

5 Things to Know About the 2026 ESC Heart Failure Guidelines

Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD

MFN Drug Agreements Could Raise Prices Worldwide

FDA Shortens Tarlatamab Monitoring, Widens Access to SCLC Care